APOE and Alzheimer disease: Previous work suggests that there may be an interactive effect of APOE4 and sex as it relates to age, where females with one copy of APOE4 have increased risk of developing AD between ages 65 and 75 compared to males with the same genotype (Neu et al., 2017); we discuss these interactions in relation to imaging variables in the paragraphs below.